Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study

PHOENIX Study Group

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Fingerprint Dive into the research topics of 'Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study'. Together they form a unique fingerprint.

Medicine & Life Sciences